VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
NEOGNeogen Corporation
$9.31$2.0B
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksNEOGPrice Target
NEOG logo

Neogen Corporation (NEOG) Price Target Analysis

Updated Jun 18, 2026
Analyst Rating: Hold
Based on 11 analysts

18.2% Below Target

NEOG trades 18.2% below Wall Street's consensus target of $11.00.

Current Price$9.31
Average Target$11.00
Target
Current
Low$10.00
Median$11.00
High$12.00

Analyst Target Range

Forward P/E25.2x
(Growth Premium)
PEG Ratio—
Implied Growth+113.3%
(High Growth)
Analyst Spread18.2%
(High Agreement)

Price Forecast (1 Year)

Last 12 months price action with 12-month analyst target path

Current$9.31
Consensus$11.00
High$12.00
Low$10.00

Consensus Scenario Assumptions

The base valuation assumes NEOG achieves its forward estimates and maintains a stable P/E multiple of 25.2x. This scenario reflects the blended consensus of 11 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.

Analyst Ratings Distribution

Breakdown of 11 published analyst recommendations for NEOG

55% hold / mixed conviction
+14
BearishBullish
Weighted analyst sentiment score based on 11 ratings
ConsensusHold
Coverage11 Analysts
Net Score+14
Bull / Bear36% / 9%
Strong Buy00%
Buy436%
Hold655%
Sell19%
Strong Sell00%
Strong Buy
00%
Buy
436%
Hold
655%
Sell
19%
Strong Sell
00%
Recommendation Mix36% Buy · 55% Hold · 9% Sell
Buy (4)Hold (6)Sell (1)

NEOG Price Target Analysis

Updated June 21, 2026

As of June 21, 2026, Neogen Corporation (NEOG) has a Wall Street consensus price target of $11.00, based on estimates from 11 covering analysts. With the stock currently trading at $9.31, this represents a potential upside of +18.2%. The company has a market capitalization of $2.03B.

Analyst price targets range from a low of $10.00 to a high of $12.00, representing a 18% spread in expectations. The median target of $11.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.

The current analyst consensus rating is Hold, with 4 analysts rating the stock as a Buy or Strong Buy,6 rating it Hold, and 1 rating it Sell or Strong Sell. The mixed ratings reflect uncertainty about near-term direction.

From a valuation perspective, NEOG trades at a trailing P/E of -1.9x and forward P/E of 25.2x. Analysts expect EPS to grow +113.3% over the next year.

Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Healthcare stocks.

Analyst Sentiment Comparison

Industry Peer Analysis
Avg Peer Upside
+27.7%
Industry Consensus
Avg Forward P/E
19.0x
(Fair)
Peers with Coverage
10 / 10
Active Analyst Tracking
CompanyMarket CapPriceTargetUpside PotentialRatingFwd P/EAnalysts
IDXX logo
IDXXIDEXX Laboratories, Inc.
$44.6B$562.09$747.50
+33.0%
Buy38.3x22
BCAL logo
BCALSouthern California Bancorp
$635M$19.74$22.00
+11.4%
Buy11.8x3
QDEL logo
QDELQuidelOrtho Corporation
$931M$13.67$12.25
-10.4%
Hold7.4x15
NVAX logo
NVAXNovavax, Inc.
$1.5B$9.13$18.00
+97.2%
Buy—23
BIO logo
BIOBio-Rad Laboratories, Inc.
$7.6B$282.44$321.67
+13.9%
Buy31.2x14
MESO logo
MESOMesoblast Limited
$1.9B$14.37$11.50
-20.0%
Buy—11
FELE logo
FELEFranklin Electric Co., Inc.
$4.6B$104.20$100.00
-4.0%
Hold22.7x11
PRAX logo
PRAXPraxis Precision Medicines, Inc.
$8.2B$282.31$584.00
+106.9%
Buy—16
TSN logo
TSNTyson Foods, Inc.
$19.7B$55.46$74.50
+34.3%
Buy13.7x30
CAG logo
CAGConagra Brands, Inc.
$6.3B$13.20$15.20
+15.2%
Hold7.8x25

NEOG — Frequently Asked Questions

Quick answers to the most common questions about buying NEOG stock.

What is the NEOG stock price target for 2026?

Neogen Corporation (NEOG) has a consensus 12-month price target of $11, implying 18.2% upside from $9.31. The 11 analysts covering NEOG see moderate appreciation potential.

Is NEOG a buy, sell, or hold?

NEOG has a consensus rating of "Hold" based on 11 Wall Street analysts. The rating breakdown is mixed, with 6 Hold ratings making up the largest segment. The consensus 12-month price target of $11 implies 18.2% upside from current levels.

Is NEOG stock overvalued or undervalued?

NEOG trades at a forward P/E of 25.1622x, representing a moderate valuation. With analysts targeting $11 (18.2% implied move), the stock appears reasonably valued with upside.

How high can NEOG stock go?

The most bullish Wall Street analyst has a price target of $12 for NEOG, while the most conservative target is $10. The consensus of $11 represents the median expectation. These targets typically reflect 12-month expectations.

How many analysts cover NEOG stock?

NEOG is moderately covered, with 11 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 4 have Buy ratings, 6 recommend Hold, and 1 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.

What is the NEOG stock forecast?

The 12-month NEOG stock forecast based on 11 Wall Street analysts shows a consensus price target of $11, with estimates ranging from $10 (bear case) to $12 (bull case). The median consensus rating is "Hold".

What is NEOG's forward P/E ratio?

NEOG trades at a forward P/E ratio of 25.2x based on next-twelve-months earnings estimates. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.

Should I buy NEOG stock?

Wall Street analysts are optimistic on NEOG, with a "Hold" consensus rating and $11 price target (18.2% upside). 4 of 11 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.

Why do NEOG price targets vary so much?

NEOG analyst price targets range from $10 to $12, a 18% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $11 consensus represents the middle ground.

Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare